Tellgen Corporation (300642.SZ)
- Previous Close
13.84 - Open
14.04 - Bid 13.93 x --
- Ask 13.94 x --
- Day's Range
13.77 - 13.99 - 52 Week Range
10.65 - 19.20 - Volume
1,454,300 - Avg. Volume
3,619,479 - Market Cap (intraday)
2.273B - Beta (5Y Monthly) --
- PE Ratio (TTM)
58.08 - EPS (TTM)
0.24 - Earnings Date --
- Forward Dividend & Yield 0.15 (1.08%)
- Ex-Dividend Date May 20, 2025
- 1y Target Est
--
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; cardiovascular and inflammation; biochemistry kits; DNA methylation testing kits; and molecular detection of COVID-19 and others. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.
www.tellgen.comRecent News: 300642.SZ
View MorePerformance Overview: 300642.SZ
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300642.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300642.SZ
View MoreValuation Measures
Market Cap
2.27B
Enterprise Value
1.90B
Trailing P/E
57.22
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.40
Price/Book (mrq)
1.51
Enterprise Value/Revenue
4.53
Enterprise Value/EBITDA
45.23
Financial Highlights
Profitability and Income Statement
Profit Margin
9.44%
Return on Assets (ttm)
2.56%
Return on Equity (ttm)
2.20%
Revenue (ttm)
418.6M
Net Income Avi to Common (ttm)
39.49M
Diluted EPS (ttm)
0.24
Balance Sheet and Cash Flow
Total Cash (mrq)
484.82M
Total Debt/Equity (mrq)
6.91%
Levered Free Cash Flow (ttm)
-15.92M